MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1210/jc.2006-2493

Медицинская библиотека · The Journal of clinical endocrinology and metabolism · 2007

Levothyroxine in euthyroid autoimmune thyroiditis and type 1 diabetes: a randomized, controlled trial.

Karges Beate, Muche Rainer, Knerr Ina, Ertelt Waldemar, Wiesel Thomas, Hub Regine, Neu Andreas, Klinghammer Albrecht, Aufschild Julia, Rapp Andrea, Schirbel Andreas, Boehm Bernhard O, Debatin Klaus M, Heinze Eberhard, Karges Wolfram

СтатьяМногоцентровое исследованиеРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

CONTEXT: Patients with type 1 diabetes (T1D) have an increased risk of autoimmune thyroiditis (AIT).

OBJECTIVE

Our objective was to determine whether levothyroxine (l-T(4)) treatment prevents the clinical manifestation of AIT in euthyroid subjects with T1D.

DESIGN AND

SETTING

We conducted a prospective, randomized, open, controlled clinical trial at six tertiary care centers for pediatric endocrinology and diabetes.

PATIENTS: Of 611 children and adolescents with T1D, 89 individuals (14.5%) were identified with positive thyroid peroxidase antibodies (TPOAb), thyroglobulin antibodies (TgAb), or both. Of these, 30 patients (age, 13.3 +/- 2.1 yr) met the inclusion criteria and were randomized to receive l-T(4) (n = 16 patients) or no treatment (n = 14 patients).

INTERVENTION: l-T(4) (1.3 microg/kg daily) was given for 24 months in the treatment group, followed by an additional observation period of 6 months in both groups.

MAIN OUTCOME MEASURES: Thyroid gland volume (as determined by ultrasound), serum levels of TSH, thyroid hormones, TPOAb, and TgAb were assessed every 6 months for 30 months.

RESULTS

Mean thyroid volume decreased in the treatment group after 24 months (-0.60 sd score) and increased in the observation group (+ 1.11 sd score; P = 0.0218). Serum thyrotropin, free T(4), TPOAb, and TgAb levels were not significantly different in both groups during the entire study period. Hypothyroidism developed in three individuals treated with l-T(4) and in four untreated patients (conversion rate, 9.3% per year).

CONCLUSIONS

In this study in euthyroid patients with AIT and T1D, l-T(4) treatment reduced thyroid volume but had no effect on thyroid function and serum autoantibody levels.

Для цитирования: Karges Beate, Muche Rainer, Knerr Ina, Ertelt Waldemar, Wiesel Thomas, Hub Regine, Neu Andreas, Klinghammer Albrecht, Aufschild Julia, Rapp Andrea, Schirbel Andreas, Boehm Bernhard O, Debatin Klaus M, Heinze Eberhard, Karges Wolfram. Levothyroxine in euthyroid autoimmune thyroiditis and type 1 diabetes: a randomized, controlled trial.. The Journal of clinical endocrinology and metabolism. 2007. DOI: 10.1210/jc.2006-2493.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.